Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 173

1.

Papillary thyroid carcinoma variants.

Lloyd RV, Buehler D, Khanafshar E.

Head Neck Pathol. 2011 Mar;5(1):51-6. doi: 10.1007/s12105-010-0236-9. Epub 2011 Jan 8. Review.

2.

Histologic variants of papillary and follicular carcinomas associated with anaplastic spindle and giant cell carcinomas of the thyroid: an analysis of rhabdoid and thyroglobulin inclusions.

Albores-Saavedra J, Hernandez M, Sanchez-Sosa S, Simpson K, Angeles A, Henson DE.

Am J Surg Pathol. 2007 May;31(5):729-36.

PMID:
17460457
3.

Correlation between BRAF mutation and the clinicopathological parameters in papillary thyroid carcinoma with particular reference to follicular variant.

Smith RA, Salajegheh A, Weinstein S, Nassiri M, Lam AK.

Hum Pathol. 2011 Apr;42(4):500-6. doi: 10.1016/j.humpath.2009.09.023. Epub 2010 Dec 16.

PMID:
21167555
4.

Uncommon BRAF mutations in the follicular variant of thyroid papillary carcinoma: New insights.

Rossi ED, Martini M, Bizzarro T, Capodimonti S, Cenci T, Lombardi CP, Pontecorvi A, Fadda G, Larocca LM.

Cancer Cytopathol. 2015 Oct;123(10):593-602. doi: 10.1002/cncy.21586. Epub 2015 Jul 31.

5.

Immunohistochemical separation of follicular variant of papillary thyroid carcinoma from follicular adenoma.

Nakamura N, Erickson LA, Jin L, Kajita S, Zhang H, Qian X, Rumilla K, Lloyd RV.

Endocr Pathol. 2006 Fall;17(3):213-23.

PMID:
17308358
6.

Immunohistochemical diagnosis of papillary thyroid carcinoma.

Cheung CC, Ezzat S, Freeman JL, Rosen IB, Asa SL.

Mod Pathol. 2001 Apr;14(4):338-42.

7.

Trefoil factor 3 immunohistochemical characterization of follicular thyroid lesions from tissue microarray.

Patel MR, Bryson PC, Shores CG, Hart CF, Thorne LB, Deal AM, Zanation AM.

Arch Otolaryngol Head Neck Surg. 2009 Jun;135(6):590-6. doi: 10.1001/archoto.2009.54.

PMID:
19528408
8.

HBME-1 and CD15 immunocytochemistry in the follicular variant of thyroid papillary carcinoma.

Ohta M, Ookoshi T, Naiki H, Imamura Y.

Pathol Int. 2015 Mar;65(3):119-25. doi: 10.1111/pin.12252. Epub 2015 Jan 19.

PMID:
25597783
9.

Immunohistochemical study of papillary thyroid carcinoma and possible papillary thyroid carcinoma-related benign thyroid nodules.

Mai KT, Ford JC, Yazdi HM, Perkins DG, Commons AS.

Pathol Res Pract. 2000;196(8):533-40.

PMID:
10982016
10.

Combined immunohistochemistry for thyroid peroxidase, galectin-3, CK19 and HBME-1 in differential diagnosis of thyroid tumors.

Paunovic I, Isic T, Havelka M, Tatic S, Cvejic D, Savin S.

APMIS. 2012 May;120(5):368-79. doi: 10.1111/j.1600-0463.2011.02842.x. Epub 2011 Nov 19.

PMID:
22515291
11.

BRAF mutations are associated with some histological types of papillary thyroid carcinoma.

Trovisco V, Vieira de Castro I, Soares P, Máximo V, Silva P, Magalhães J, Abrosimov A, Guiu XM, Sobrinho-Simões M.

J Pathol. 2004 Feb;202(2):247-51.

PMID:
14743508
12.
13.

[Diagnosis of the follicular variant of papillary thyroid carcinoma. Significance of immunohistochemistry].

Guyétant S, Michalak S, Valo I, Saint-André JP.

Ann Pathol. 2003 Feb;23(1):11-20. French.

PMID:
12743496
14.

CXC chemokine receptor 4 immunodetection in the follicular variant of papillary thyroid carcinoma: comparison to galectin-3 and hector battifora mesothelial cell-1.

Torregrossa L, Faviana P, Filice ME, Materazzi G, Miccoli P, Vitti P, Fontanini G, Melillo RM, Santoro M, Basolo F.

Thyroid. 2010 May;20(5):495-504. doi: 10.1089/thy.2009.0282.

PMID:
20450430
15.

[Comparison of CD15, galectin-3 and HBME-1 expression in follicular thyroid neoplasms].

Bogdańska M, Górnicka B, Ziarkiewicz-Wróblewska B, Koperski L, Morton M, Wasiutyński A.

Endokrynol Pol. 2006 Jul-Aug;57(4):314-9. Polish.

PMID:
17006830
16.
17.

Variants of papillary carcinoma of the thyroid: experience at Asir Central Hospital.

Khan AR, Abu-Eshy SA.

J R Coll Surg Edinb. 1998 Feb;43(1):20-5.

PMID:
9560501
18.

CD57 (Leu-7) expression is helpful in diagnosis of the follicular variant of papillary thyroid carcinoma.

Khan A, Baker SP, Patwardhan NA, Pullman JM.

Virchows Arch. 1998 May;432(5):427-32.

PMID:
9645441
19.

Expression of epithelial-mesenchymal transition regulators SNAI2 and TWIST1 in thyroid carcinomas.

Buehler D, Hardin H, Shan W, Montemayor-Garcia C, Rush PS, Asioli S, Chen H, Lloyd RV.

Mod Pathol. 2013 Jan;26(1):54-61. doi: 10.1038/modpathol.2012.137. Epub 2012 Aug 17.

20.

A morpho-molecular diagnosis of papillary thyroid carcinoma: BRAF V600E detection as an important tool in preoperative evaluation of fine-needle aspirates.

Marchetti I, Lessi F, Mazzanti CM, Bertacca G, Elisei R, Coscio GD, Pinchera A, Bevilacqua G.

Thyroid. 2009 Aug;19(8):837-42. doi: 10.1089/thy.2009.0074.

PMID:
19534623

Supplemental Content

Support Center